Is Sentinel Lymph Node Dissection Warranted for Patients With a Diagnosis of Ductal Carcinoma in Situ?

Annals of Surgical Oncology - United States
doi 10.1245/s10434-015-4547-7
Full Text
Abstract

Available in full text

Categories
OncologySurgery
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Utilization of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma in Situ Undergoing Mastectomy

Annals of Surgical Oncology
OncologySurgery
2012English

Ductal Carcinoma in Situ and Sentinel Lymph Node Metastasis in Breast Cancer

World Journal of Surgical Oncology
SurgeryOncology
2010English

Role of Axillary Sentinel Lymph Node Biopsy in Patients With Pure Ductal Carcinoma in Situ of the Breast

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

Utilization of Lymph Node Assessment in Patients With Ductal Carcinoma in Situ Treated With Lumpectomy

Journal of Surgical Research
Surgery
2012English

Impact of Completion Lymph Node Dissection on Patients With Positive Sentinel Lymph Node Biopsy in Melanoma

Journal of the American College of Surgeons
Surgery
2016English

Correction To: Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

Current Treatment Options in Oncology
OncologyPharmacology
2019English

Radioguided Sentinel Lymph Node Biopsy in Patients With Papillary Thyroid Carcinoma

Gland Surgery
Surgery
2016English

Incidence and Consequence of Close Margins in Patients With Ductal Carcinoma-In Situ Treated With Mastectomy: Is Further Therapy Warranted?

Breast Diseases
OncologySurgery
2014English

The Role of Sentinel Lymph Node Biopsy in Patients With B5c Breast Cancer Diagnosis

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy